Evaluation of the immunogenicity of recombinant replicative DNA vaccines expressing multiple anti-gens of hepatitis C virus in a mice model
10.3760/cma.j.issn.0254-5101.2015.03.010
- VernacularTitle:表达丙型肝炎病毒多个融合抗原的复制型DNA 疫苗在小鼠体内免疫原性的研究
- Author:
Yao DENG
;
Jie GUAN
;
Xiao YIN
;
Bo WEN
;
Hong CHEN
;
Wen WANG
;
Wenjie TAN
- Publication Type:Journal Article
- Keywords:
Hepatitis C virus;
Replicative DNA vaccine;
Fusion antigen;
T cell response
- From:Chinese Journal of Microbiology and Immunology
2015;(3):202-206
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the immunogenicity and cross protective effects of two novel HCV DNA vaccines in a mice model.Methods Two self-replicating alphavirus vector-based HCV DNA vaccines, pSCK CE1E2Y and pSCK H155, were constructed based on the genes encoding the structural pro-teins (Core, E1 and E2) and structural and NS3 fusion proteins (Core, E1 , E2 and NS3) of a HCV strain isolated from a Chinese patient (genotype 1b, Hebei strain), respectively.Western blot analysis was per-formed to detect the expression of fusion antigens.The BALB/c mice were intradermally immunized with the recombinant DNA vaccines by using electroporation.The immune responses induced in mice and the cross protective effects of the recombinant DNA vaccines were evaluated.Results The DNA vaccines effectively expressed the target antigens in vitro.The antigen-specific antibody responses and specific T cell immune re-sponses were induced in mice by the immunization of replicative DNA vaccines.However, no effective cross protection was provided by either of the DNA vaccines in the surrogate challenge model based on a recombi-nant heterologous HCV (JFH1, 2a) vaccinia virus strain.Conclusion Although no effective cross protec-tion was observed, both of the two replicative DNA vaccines could induce strong humoral and cellular im-mune responses against multi-target antigens of HCV strains.This study has paved the way for further inves-tigation on the development of novel HCV vaccines.
